Pandion Therapeutics Inc. (PAND) is a public company listed on NASDAQ. There were no new wire items for PAND in the last 30 days. The most recent was published May 17, 2021.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Pandion Therapeutics Inc. (Amendment)SC 13G/A - Pandion Therapeutics, Inc. (0001807901) (Subject)
- SECSEC Form 15-12B filed by Pandion Therapeutics Inc.15-12B - Pandion Therapeutics, Inc. (0001807901) (Filer)
- 13D/GSEC Form SC 13D/A filed by Pandion Therapeutics Inc. (Amendment)SC 13D/A - Pandion Therapeutics, Inc. (0001807901) (Subject)
- SECSEC Form EFFECT filed by Pandion Therapeutics Inc.EFFECT - Pandion Therapeutics, Inc. (0001807901) (Filer)
- SECSEC Form EFFECT filed by Pandion Therapeutics Inc.EFFECT - Pandion Therapeutics, Inc. (0001807901) (Filer)
- 13D/GSEC Form SC 13D/A filed by Pandion Therapeutics Inc. (Amendment)SC 13D/A - Pandion Therapeutics, Inc. (0001807901) (Subject)
- INSIDERSEC Form 4: L. Joanne Viney decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: Vikas Goyal decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: L Alan Crane decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: D. Edward Freedman decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4 filed by Gregg Beloff4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: Rahul Kakkar decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4 filed by Christopher Fuglesang4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: J. Daniel Becker decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: John Sundy decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: Nancy Stagliano decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4 filed by Katina Dorton4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: Donald Frail decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4 filed by Jill Carroll4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4 filed by Rizzuto Carlo4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- INSIDERSEC Form 4: D Eric Larson decreased direct ownership by 100% to 0 units4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
- SECSEC Form S-8 POS filed by Pandion Therapeutics Inc.S-8 POS - Pandion Therapeutics, Inc. (0001807901) (Filer)
- SECSEC Form S-8 POS filed by Pandion Therapeutics Inc.S-8 POS - Pandion Therapeutics, Inc. (0001807901) (Filer)
- SECSEC Form POS AM filed by Pandion Therapeutics Inc.POS AM - Pandion Therapeutics, Inc. (0001807901) (Filer)
- SECSEC Form POS AM filed by Pandion Therapeutics Inc.POS AM - Pandion Therapeutics, Inc. (0001807901) (Filer)
PAND FAQ
6 questionsWhat is the latest news on PAND?
Quantisnow has not tracked any new filings, ratings or press releases for PAND in the last 30 days. The most recent wire item was published on May 17, 2021.Where does PAND stock trade?
Pandion Therapeutics Inc. (PAND) is listed on NASDAQ.What sector and industry is PAND in?
Pandion Therapeutics Inc. operates in the n/a sector.When did Pandion Therapeutics Inc. go public?
Pandion Therapeutics Inc. (PAND) completed its IPO in 2020.What companies are similar to PAND?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare PAND side-by-side with any of them on Quantisnow.How can I track PAND on Quantisnow?
Quantisnow aggregates Pandion Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PAND to receive live email and push alerts on every new disclosure.